Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOWRI: Metformin for Weight Loss in Obese, Non-diabetic People
NCT07297290Phase 3Recruiting
- Sponsor
- University of Nigeria Teaching Hospital
- Start
- Jul 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in obesity, sponsored by University of Nigeria Teaching Hospital. Started Jul 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07297290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07297290.